top of page

Google Parent and Sanofi Name Diabetes Joint Venture Onduo

Joint venture will research diabetes treatments

Joshua Riff, who was a senior executive at UnitedHealth Group’s Optum, will be CEO of the new unit. PHOTO: EUROPEAN PRESSPHOTO AGENCY

PARIS—French pharmaceutical group Sanofi SA is joining with Verily Life Sciences LLC, a unit of Google parent Alphabet, to create a joint venture called Onduo to research diabetes treatments.

“Onduo’s mission is to help people with diabetes live full, healthy lives by developing comprehensive solutions that combine devices, software, medicine, and professional care to enable simple and intelligent disease management,” Sanofi and Verily, which was previously known as Google Life Science, said.

The two companies appointed Joshua Riff, who was a senior executive at UnitedHealth Group’s Optum, as the chief executive of the new unit.

Sanofi is a leading maker of diabetes medication, as well as many other drugs. Onduo will combine Verily’s experience in miniaturized electronics, analytics, and consumer software development, and Sanofi’s clinical expertise and experience in providing treatment to diabetic people.

Sanofi is seeking new diabetes treatments as revenue from its diabetes drugs in the U.S. fell after its insulin Lantus lost patent protection there.Diabetes is expected to affect 592 million people world-wide by 2035, according to the International Diabetes Federation.

Featured Posts
Recent Posts

About pharmanaming.com

The Global Naming Network (GNN), headquartered in Geneva, is the world's largest network of independent naming and brand identity agencies.

 

With 16 offices and around 120 cooperating naming and branding specialists in 11  countries, from Shanghai to New York and from Seoul to Paris, GNN works for clients ranging from large multinationals to small startups all over the world.

Healthcare and pharmaceutical projects are coordinated from the GNN partner office of Readge consultants in Rijswijk.

 

Please get in touch for more information.

16

offices in 11 countries

120

creatives, strategists & consultants

GNN partners

China                     South Korea

France                   Italy
Germany               Japan

Netherlands         UK

India                      Singapore

Spain                     Canada

Switzerland          Russia

USA                       Dubai

5000

projects successfully executed

Pages

home                           name to brand

health & pharma        people

regulatory                   test & submit

India                            FDA

work                            blog

clients                         contact

>20000

linguistic professionals worldwide

Global Naming Network

© 2025 by Readge consultants

Leeuwendaallaan 24, 2281 GP Rijswijk, the Netherlands

call +31 653528944 or mail to pharma@globrands.com  

 

  • White LinkedIn Icon
bottom of page